SCHEMBL29641509

SCHEMBL29641509

CC(c1cccc(-c2c(C(C)n3nc(I)c4c(N)ncnc43)oc(=O)c3ccccc23)c1)N(C)C

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 10/20 0.44
▸ SRC P12931 6/20 0.42
▸ ABL1 P00519 5/20 0.42
▸ PIK3CG P48736 6/20 0.41
▸ PIK3R1 P27986 1/20 0.41
▸ CSNK1E P49674 1/20 0.41
▸ PIK3CA P42336 4/20 0.37
▸ PRKDC P78527 4/20 0.37
▸ EGFR P00533 3/20 0.37
▸ HCK P08631 3/20 0.37
▸ KDR P35968 3/20 0.37
▸ MTOR P42345 3/20 0.37
▸ EPHB4 P54760 3/20 0.37
▸ PI4KB Q9UBF8 3/20 0.37
▸ PIK3CB P42338 3/20 0.37
▸ BCHE P06276 4/20 0.37
▸ ACHE P22303 4/20 0.37
▸ RET P07949 1/20 0.36
▸ FYN P06241 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22504971 1.00 PIK3CD (0.44) PIK3CDSRCABL1PIK3CGPIK3R1
SCHEMBL24494672 0.92 PIK3CD (0.45) PIK3CDSRCABL1PIK3CGPIK3R1
SCHEMBL16783471 0.89 PIK3CD (0.45) PIK3CDSRCABL1PIK3CGPIK3R1
SCHEMBL16783451 0.88 SRC (0.48) PIK3CDSRCABL1PIK3CGPIK3R1
SCHEMBL16783414 0.87 PIK3CD (0.44) PIK3CDSRCABL1PIK3CGPIK3R1
SCHEMBL29641490 0.85 PIK3CD (0.46) PIK3CDSRCABL1PIK3CGPIK3R1
SCHEMBL22504974 0.85 PIK3CD (0.46) PIK3CDSRCABL1PIK3CGPIK3R1
SCHEMBL22498306 0.82 PIK3CD (0.41) PIK3CDSRCABL1PIK3CGPIK3R1
SCHEMBL16783796 0.82 PIK3CD (0.42) PIK3CDSRCABL1PIK3CGPIK3R1
SCHEMBL26695707 0.82 PIK3CD (0.42) PIK3CDSRCABL1PIK3CGPIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12527797-B2 Isochromene derivatives as phosphoinositide 3-kinases inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2026-01-20 — — US disclosed
US-20220175784-A1 ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2022-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220175784-A1 ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS PIKFYVE, PDPK1, PIK3R5 PIK3CD 5/4885SRC 157/4885ABL1 136/4885
US-12527797-B2 Isochromene derivatives as phosphoinositide 3-kinases inhibitors PIK3R5, PIK3CD, PIK3R4 PIK3CD 2/4885SRC 190/4885ABL1 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback